Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
出版年份 2010 全文链接
标题
Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 9, Issue 9, Pages 1055-1069
出版商
Informa UK Limited
发表日期
2010-09-07
DOI
10.1586/erv.10.106
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Attenuated poxvirus vectors MVA and NYVAC as promising vaccine cadidates against HIV/AIDS
- (2014) Mariano Esteban Human vaccines & immunotherapeutics
- Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodies
- (2010) M Patricia DʼSouza et al. AIDS
- A Phase 1/2 Study of a Multiclade HIV‐1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV‐Uninfected East Africans (RV 172)
- (2010) Hannah Kibuuka et al. JOURNAL OF INFECTIOUS DISEASES
- Host Determinants of HIV‐1 Control in African Americans
- (2010) Kimberly Pelak et al. JOURNAL OF INFECTIOUS DISEASES
- Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV‐1 Vaccine Candidates
- (2010) Aggeliki Spentzou et al. JOURNAL OF INFECTIOUS DISEASES
- Novel Recombinant Mycobacterium bovis BCG, Ovine Atadenovirus, and Modified Vaccinia Virus Ankara Vaccines Combine To Induce Robust Human Immunodeficiency Virus-Specific CD4 and CD8 T-Cell Responses in Rhesus Macaques
- (2010) M. Rosario et al. JOURNAL OF VIROLOGY
- Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
- (2010) Sampa Santra et al. NATURE MEDICINE
- Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine
- (2010) Sandhya Vasan et al. PLoS One
- Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine
- (2010) Sandhya Vasan et al. PLoS One
- Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization
- (2010) Vainav Patel et al. VACCINE
- Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
- (2009) Susan W Barnett et al. AIDS
- A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian Volunteers
- (2009) Vadakkuppatu Devasenapathi Ramanathan et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity
- (2009) Charani Ranasinghe et al. Expert Review of Vaccines
- Plasmid-Encoded Interleukin-15 Receptor α Enhances Specific Immune Responses Induced by a DNA Vaccine In Vivo
- (2009) Kimberly A. Kraynyak et al. HUMAN GENE THERAPY
- Preclinical and Clinical Development of a Multi-Envelope, DNA-Virus-Protein (D-V-P) HIV-1 Vaccine
- (2009) Robert Sealy et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity
- (2009) M. Honda et al. JOURNAL OF IMMUNOLOGY
- Comparative Cell‐Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV‐1 Clade BgagVaccine Prime‐Boost Regimens
- (2009) David M. Asmuth et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens
- (2009) P. Mooij et al. JOURNAL OF VIROLOGY
- Improved Survival in Rhesus Macaques Immunized with Modified Vaccinia Virus Ankara Recombinants Expressing Simian Immunodeficiency Virus Envelope Correlates with Reduction in Memory CD4+ T-Cell Loss and Higher Titers of Neutralizing Antibody
- (2009) I. Ourmanov et al. JOURNAL OF VIROLOGY
- Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge
- (2009) N. A. Wilson et al. JOURNAL OF VIROLOGY
- Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
- (2009) M. D. Simek et al. JOURNAL OF VIROLOGY
- Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination
- (2009) M Manrique et al. Mucosal Immunology
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
- (2009) Scott G Hansen et al. NATURE MEDICINE
- Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
- (2009) Ann J Hessell et al. NATURE MEDICINE
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector
- (2009) LR Baden et al. Retrovirology
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
- Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity
- (2009) Lindvi Gudmundsdotter et al. VACCINE
- Preclinical Evaluation of the Immunogenicity of C-Type HIV-1-Based DNA and NYVAC Vaccines in the Balb/C Mouse Model
- (2009) Jens Wild et al. VIRAL IMMUNOLOGY
- Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
- (2009) Ann J. Hessell et al. PLoS Pathogens
- Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults
- (2008) Clayton D. Harro et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults
- (2008) Frances H. Priddy et al. CLINICAL INFECTIOUS DISEASES
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development
- (2008) L Jean Patterson et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- DNA vaccines: developing new strategies to enhance immune responses
- (2008) Shaheed A. Abdulhaqq et al. IMMUNOLOGIC RESEARCH
- Macaques vaccinated with live-attenuated SIV control replication of heterologous virus
- (2008) Matthew R. Reynolds et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Measuring HIV‐1–Specific T Cell Immunity: How Valid Are Current Assays?
- (2008) M. Patricia D’Souza et al. JOURNAL OF INFECTIOUS DISEASES
- Cross‐Clade Detection of HIV‐1–Specific Cytotoxic T Lymphocytes Does Not Reflect Cross‐Clade Antiviral Activity
- (2008) Michael S. Bennett et al. JOURNAL OF INFECTIOUS DISEASES
- Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara
- (2008) Eric Sandström et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy
- (2008) Florencia Pereyra et al. JOURNAL OF INFECTIOUS DISEASES
- Genomewide Association Study of an AIDS‐Nonprogression Cohort Emphasizes the Role Played byHLAGenes (ANRS Genomewide Association Study 02)
- (2008) Sophie Limou et al. JOURNAL OF INFECTIOUS DISEASES
- DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles
- (2008) K. S. Cox et al. JOURNAL OF VIROLOGY
- Failure of the Merck HIV vaccine: an uncertain step forward
- (2008) Merlin L Robb LANCET
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
- (2008) M Juliana McElrath et al. LANCET
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- Challenges in the development of an HIV-1 vaccine
- (2008) Dan H. Barouch NATURE
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
- (2008) Jinyan Liu et al. NATURE
- Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
- (2008) David I Watkins et al. NATURE MEDICINE
- The Challenge of HIV-1 Subtype Diversity
- (2008) Barbara S. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic
- (2008) M. Corbett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV Vaccine Research: The Way Forward
- (2008) A. S. Fauci et al. SCIENCE
- EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
- (2008) Pierre-Alexandre Bart et al. VACCINE
- Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers
- (2008) A. Guimarães-Walker et al. VACCINE
- Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation
- (2008) Margherita Rosati et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search